Kimberly Clark (KMB) reportedly preparing asset sales in bid for EU approval of the USD 40bln Kenvue (KVUE) deal, according to source reports

The tells are familiar. Offers reported early in the review tend to indicate the parties want a Phase I clearance, which historically has carried a lower bar and a faster timetable; a package that emerges late or after a statement of objections usually means deeper concessions. The asset mix matters more than the headline value, since the Commission has in past cases rejected buyer-of-last-resort carve-outs where the divested brands lacked a credible purchaser or an integrated supply chain, and where it has required upfront-buyer structures. For the spread, the established pattern is that confirmed remedy negotiations tighten the deal spread toward the regulatory-risk component rather than eliminating it, with completion risk then hinging on remedy sufficiency and timing rather than on financing. Worth observing is whether other jurisdictions follow with parallel concerns, whether a named buyer emerges for the divested assets, and whether the parties extend the long-stop date, each of which has been the recurring pressure point in deals of this size. As a source-reported item rather than a company confirmation, the report is directional.